NASDAQ:SNNA - Nasdaq -
0.1358
+0.03 (+34.46%)
The current stock price of SNNA is 0.1358 null. In the past month the price decreased by -35.33%. In the past year, price decreased by -95.04%.
Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake Village, United States.
SIENNA BIOPHARMACEUTICALS INC
30699 Russell Ranch Road Suite 140
Westlake Village CA 91362
CEO: Frederick C. Beddingfield III
Phone: 818-629-2256
The current stock price of SNNA is 0.1358 null. The price increased by 34.46% in the last trading session.
The exchange symbol of SIENNA BIOPHARMACEUTICALS INC is SNNA and it is listed on the Nasdaq exchange.
SNNA stock is listed on the Nasdaq exchange.
SIENNA BIOPHARMACEUTICALS INC (SNNA) has a market capitalization of 4.20M null. This makes SNNA a Nano Cap stock.
SIENNA BIOPHARMACEUTICALS INC (SNNA) has a resistance level at 0.17. Check the full technical report for a detailed analysis of SNNA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SNNA does not pay a dividend.
SIENNA BIOPHARMACEUTICALS INC (SNNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).
ChartMill assigns a fundamental rating of 3 / 10 to SNNA. SNNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months SNNA reported a non-GAAP Earnings per Share(EPS) of -2.0300000000000002. The EPS increased by 37.15% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -110.25% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 100% to SNNA. The Buy consensus is the average rating of analysts ratings from 2 analysts.